Treatment for Prostate Cancer With Seminal Vesicle Invasion

Prostate cancer that has grown into the seminal vesicles, the two small glands that sit behind the prostate, is called locally advanced. It is still usually treated with the goal of cure. Treatment almost always combines approaches, built around radiation or surgery plus hormone therapy, rather than relying on one treatment alone. The label covers a wide range of situations, though, and how the cancer got into the seminal vesicles and what else the report shows can move the outlook from very good to more guarded.¹

What Seminal Vesicle Invasion Means for Your Stage and Outlook

Doctors write seminal vesicle invasion as T3b, or pT3b when it is confirmed in tissue removed at surgery. It puts the cancer in the high-risk group, where the main worry is a PSA rise after treatment, which doctors may call PSA or biochemical recurrence. Spread into the seminal vesicles roughly doubles the chance of a rising PSA compared with cancer that hasn’t reached them.² The outlook is not uniformly poor, though, and routine pathology can sort these cancers into groups with quite different prospects.³

How the cancer got into the seminal vesicles matters. It can grow straight through the prostate’s outer layer, or it can arrive as a small separate deposit.⁴ Cancers that grow straight through carried lymph node spread in about 1 in 3 cases, compared with about 1 in 12 otherwise.⁵ Cancer that only reaches the muscle wall of the gland returned in about 16% of men, while cancer reaching the inner lining carried a much higher risk.⁶

So when you read your pathology report, look for whether the invasion is in the muscle wall or the lining, and ask whether it was direct growth or a separate deposit.

Gleason grade, which describes how aggressive the cells look, and the PSA level at diagnosis are read together with the stage. Whether the lymph nodes look clear, on imaging or at surgery, is one of the biggest things that moves an outlook up or down. Margins, the edges of tissue removed at surgery, matter too. Ask your doctor which of your features push the risk up or down.

How Doctors Find Seminal Vesicle Invasion Before Treatment

MRI catches only about 35% of seminal vesicle invasion that is later found at surgery.⁷ A PSMA PET scan, which uses a tracer that sticks to prostate cancer cells, catches about 44 to 55%.⁸ When either scan does show invasion, it is usually right, with false alarms in only about 2 to 6% of men without it.⁹ Using MRI and PSMA together raised detection to about 60%.¹⁰ A clear scan therefore does not rule invasion out, and some men only learn of it after surgery.

Tiny deposits inside the vesicle wall fall below the size scans can show, while the surgery report examines the actual tissue under a microscope. Learning of T3b after surgery is common and changes follow-up plans, but it does not mean the scan was done badly.

Because scans miss many real cases, doctors treat the risk as a probability, using PSA, Gleason grade and biopsy findings along with the images. If the biopsy is very aggressive or the PSA is high, they may plan treatment that covers the seminal vesicles even when the scan looks clear. It is worth asking whether you had MRI, PSMA, or both, whether a seminal vesicle biopsy would change the plan, and how the scan findings shaped the treatment you were offered.

Radiation With Long-Term Hormone Therapy

Radiation is aimed at the prostate and the full seminal vesicles, and often the pelvic lymph nodes too.¹¹ The involved seminal vesicle usually gets about the same high dose as the prostate, around 76 to 77 Gy.¹² Shorter courses with somewhat larger daily doses appear appropriate at full dose for T3b cancer.¹³ Some men also get brachytherapy, radioactive seeds placed in the prostate, as a boost on top of external radiation.¹⁴

Before treatment starts, you have a planning CT scan, sometimes with an MRI, so the team can map the prostate, seminal vesicles and nearby organs. Staff may make small skin marks or tiny tattoos so you are lined up the same way at every session. Physicists and your radiation oncologist then calculate the plan, which usually takes a week or two. Ask whether the pelvic lymph nodes are included, since that changes how large the treated area is.

Treatment is usually given on weekdays over about five to eight weeks. Each session takes minutes and is painless, and you may be asked to keep a comfortably full bladder.

Hormone therapy, also called androgen deprivation therapy or ADT, lowers testosterone, which prostate cancer uses to grow. It often starts a few months before radiation. Two years of it with high-dose radiation improved PSA control and survival compared with a short course, especially for high-risk cancer, and the longer course did not increase late radiation side effects.¹⁵ Hormones shrink the cancer and help radiation work better, and they also treat tiny cancer cells outside the radiation area. Stopping too early lowers the benefit for high-risk cancer.

In men with cancer proven in the seminal vesicles who were treated with hormones, seeds and external radiation, about 61% were free of PSA recurrence at 15 years.¹⁶ About 70% were still alive without dying of prostate cancer at 15 years, while 32% died of it, a higher share than for men without invasion.¹⁷

Surgery for Seminal Vesicle Invasion

Surgery removes the prostate and both seminal vesicles, and some surgeons take wider tissue around them for better control.¹⁸ The surgical margin is the edge of the removed tissue; a positive margin means cancer reached that edge. With clean margins and no node spread, about 72% stayed free of a PSA rise at 5 years, against about 37% with positive margins.¹⁹ Cancer-specific survival at 5 years was 100% with clean margins and no node spread.²⁰

One cancerous lymph node did not worsen 10-year outcomes among men with seminal vesicle invasion, with about 4 in 5 free of spread.²¹ Two or more positive nodes did predict worse survival.²² PSA level and Gleason grade also predicted recurrence after surgery.²³²⁴

Neither surgery nor radiation has been proven clearly better for T3b. Surgery gives a full pathology report to guide next steps, but many men who choose it later need radiation too. Age and health often guide the choice.

Surgery usually suits men who are healthy enough for a major operation and expect to live many more years. Significant urinary problems or other health conditions may steer a man toward radiation. Results also depend partly on the operation being done well, so ask the surgeon about the team’s experience.

Afterward, the removed prostate and seminal vesicles go to a pathologist, who writes the report showing the true stage, margins, Gleason grade and, if nodes were removed, whether they hold cancer. Your first PSA is usually checked some weeks after surgery, once healing has finished, and it should fall to almost nothing. The report and that first PSA together decide whether you simply watch or plan radiation.

Radiation After Surgery and When to Start It

In older data, men with pT3b who got radiation soon after surgery were far more often free of a PSA rise at 5 years, 80% against 8%.²⁵ The men who did not get early radiation were often treated only when problems appeared and followed with less sensitive PSA tests, so a rise was caught later than it would be today. The figure shows the value of radiation in that setting, not that every man needs it straight away.

Newer trials use more sensitive tests and treat at the first small rise, and they suggest early radiation at that point gives similar cancer control to routine radiation.²⁶ Waiting spares many men radiation they never needed, and its side effects.²⁷

With watching, tests come every few months at first, and a small confirmed rise triggers radiation rather than more waiting. Missing tests undermines the approach.

When radiation is given after surgery, adding 24 months of hormone therapy instead of 6 improved freedom from spread.²⁸ The benefit comes with longer hot flushes and fatigue, and the trial advice is to offer it if men accept the side effects. Discuss your margins and nodes to judge your personal benefit.

Newer Drugs Added for High-Risk Cancer

Adding abiraterone with prednisolone to hormone therapy and radiation for high-risk cancer kept 82% free of spread at 6 years, against 69%.²⁹ Adding enzalutamide on top of abiraterone did not help further.³⁰ Abiraterone also improved overall survival in high-risk cancer.³¹

Abiraterone is a daily pill taken with a steroid, and blood pressure and liver tests are checked along the way. The trial that showed benefit enrolled men with high-risk cancer that had not spread to distant sites and who were starting hormone therapy with radiation. It strengthens standard treatment for the highest-risk men and is not a drug every man with seminal vesicle invasion needs. Your Gleason grade, PSA and node findings help your team judge whether you fall in that group. If your risk is lower, standard hormone therapy with radiation may be enough, and the extra drug adds side effects without clear gain.

Lutetium-PSMA, a radioactive drug that seeks out cancer cells, is being tested before surgery. It is safe and lowers PSA, yet a single dose rarely clears all cancer.³² Strong hormone drugs given before surgery are also being studied in trials, though earlier trials of hormone therapy before surgery did not reduce seminal vesicle invasion.³³

Clinical trials can offer newer drugs, and they still include standard treatment. Ask your cancer team whether you qualify for any.

Side Effects and Life During Treatment

The most common serious hormone effect is loss of erections and sex drive, reported as severe in about 1 in 3 men on long-term therapy.³⁴ Other notable effects include hot flushes and urinary frequency.³⁵ Lower testosterone also commonly brings tiredness and sometimes weight gain or muscle loss. Some men notice changes in mood or sleep.

Sexual function often improved within 9 months after short hormone treatment ended.³⁶ Long-term hormones with radiation did not raise the risk of fatal heart problems.³⁷

Exercise helps with fatigue and with bone and muscle loss, and it is worth asking about bone density checks. Hot flushes often ease with time and treatment, and some of the other effects have treatments too, so raise any of them with your team.

Radiation brings bladder and bowel effects, and most are mild. Combining seeds and external radiation can steadily worsen urinary symptoms over about 2 years.³⁸ Report urgency or bleeding to your team. Pelvic floor exercises may help.

Making the Decision With Your Care Team

Teams of different specialists play an important role in shared decisions for advanced prostate cancer.³⁹ Ask to see both a surgeon and a radiation oncologist before choosing.

Useful questions to bring: What does my report show about margins, nodes and grade? What is my chance of cure with each option? How long would hormones last? Which side effects matter most to my life?

Second opinions are common and expected. Bring your scans and reports.